FDA Office of Generic Drugs Elevated to ‘Super Office’

Drug Industry Daily
A A
HHS has approved the overhaul of the FDA's Office of Generic Drugs (OGD), allowing the agency to move most of its functions relating to generic drugs under one roof.

To View This Article:

Login

Subscribe To Drug Industry Daily